{"transactions":[{"id":945841,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:55:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7180,"price":8.76,"value":62896.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $62,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":7180,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":7180},"source":{"system":"sec-edgar","filing":"0001507567-26-000003","document":"wk-form4_1767743714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000150756726000003/wk-form4_1767743714.xml","form_type":"4"}},{"id":945840,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:55:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001507567-26-000003","document":"wk-form4_1767743714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000150756726000003/wk-form4_1767743714.xml","form_type":"4"}},{"id":1309852,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T18:57:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6855,"price":9.18,"value":62928.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $62,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":6855,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6855},"source":{"system":"sec-edgar","filing":"0001599298-25-000022","document":"wk-form4_1736207824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929825000022/wk-form4_1736207824.xml","form_type":"4"}},{"id":1309851,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T18:57:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000022","document":"wk-form4_1736207824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929825000022/wk-form4_1736207824.xml","form_type":"4"}},{"id":1687146,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:27:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":47651,"price":1.32,"value":62899.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $62,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":82651,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":47651},"source":{"system":"sec-edgar","filing":"0001599298-24-000014","document":"wk-form4_1704403621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929824000014/wk-form4_1704403621.xml","form_type":"4"}},{"id":1687145,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:27:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000014","document":"wk-form4_1704403621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929824000014/wk-form4_1704403621.xml","form_type":"4"}},{"id":2061844,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T16:21:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":32700,"price":1.67,"value":54609.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":67700,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":32700},"source":{"system":"sec-edgar","filing":"0001507567-23-000003","document":"wf-form4_167295366118350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000150756723000003/wf-form4_167295366118350.xml","form_type":"4"}},{"id":2061843,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T16:21:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001507567-23-000003","document":"wf-form4_167295366118350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000150756723000003/wf-form4_167295366118350.xml","form_type":"4"}},{"id":2146998,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T16:50:56.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on September 28, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022."}],"balance_after":206250,"derivative":{"exercise_price":1.21,"expiration_date":"2032-09-28","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001839882-22-022703","document":"booth-form4_093022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000183988222022703/booth-form4_093022.xml","form_type":"4"}},{"id":2146997,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T16:50:56.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 28, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on September 28, 2023."}],"balance_after":200000,"derivative":{"exercise_price":1.21,"expiration_date":"2032-09-28","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001839882-22-022703","document":"booth-form4_093022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000183988222022703/booth-form4_093022.xml","form_type":"4"}},{"id":3681490,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-31T17:19:02.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":27705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from January 1, 2019."}],"balance_after":27705,"derivative":{"exercise_price":8.43,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":27705},"source":{"system":"sec-edgar","filing":"0001333277-19-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327719000019/edgar.xml","form_type":"4"}},{"id":4088440,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-26T16:55:50.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018."}],"balance_after":16000,"derivative":{"exercise_price":11.69,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001333277-18-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327718000019/edgar.xml","form_type":"4"}},{"id":4201678,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T09:30:16.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017, subject to the Reporting Person's continuous service to the Issuer as of each such date. The option allows for early exercise by the Reporting Person."}],"balance_after":7500,"derivative":{"exercise_price":7.47,"expiration_date":"2027-09-21","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-053895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000120919117053895/doc4.xml","form_type":"4"}},{"id":4269478,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T14:42:31.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001042074-17-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000104207417000014/primary_doc.xml","form_type":"4"}},{"id":4484242,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-23T17:56:13.000Z","date":"2017-01-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three annual installments from the vesting start date of December 6, 2016."}],"balance_after":30000,"derivative":{"exercise_price":1.72,"expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-17-001182","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000117911017001182/edgar.xml","form_type":"4"}}]}